Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 18,160 shares at $319.76 ($5.9M) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($5.9M) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $319.76 | 1,000 | $320K | 5.4% |
| 2 | $320.92 | 1,400 | $449K | 7.6% |
| 3 | $321.91 | 600 | $193K | 3.3% |
| 4 | $326.89 | 15,160 | $5.0M | 83.7% |
| Total | $325.88 avg | 18,160 | $5.9M | 100% |
| Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |
| NTRA | SELL | 2026-06-03 | $655K | — | Filing → |